FLUPHENAZINE DECANOATE

FLUPHENAZINE DECANOATE was reported 435 times

FLUPHENAZINE DECANOATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYSTERICAL PSYCHOSIS 1 0.0588
1 COPROLALIA 2 0.0351
2 ORTHOSTATIC HYPERTENSION 16 0.0274
3 CAMPTOCORMIA 6 0.0250
4 VON WILLEBRAND'S DISEASE 1 0.0182
5 CORNEAL PIGMENTATION 1 0.0175
6 ANOSOGNOSIA 12 0.0156
7 BLUNTED AFFECT 11 0.0149
8 THOUGHT INSERTION 1 0.0143
9 BLOOD PROLACTIN ABNORMAL 12 0.0139
10 PLATELET AGGREGATION DECREASED 1 0.0132
11 TRANSIENT PSYCHOSIS 1 0.0122
12 THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED 1 0.0105
13 BACTERIA URINE 1 0.0104
14 IDEAS OF REFERENCE 1 0.0098
15 ACCOMMODATION DISORDER 7 0.0096
16 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 2 0.0087
17 NEUROMUSCULAR TOXICITY 3 0.0085
18 HYPOOSMOLAR STATE 1 0.0081
19 PERFORATED ULCER 6 0.0079
20 PANCREATIC HAEMORRHAGE 1 0.0076
21 REFUSAL OF EXAMINATION 1 0.0076
22 HYPEROSMOLAR HYPERGLYCAEMIC STATE 1 0.0071
23 EMOTIONAL POVERTY 12 0.0068
24 PANCREATITIS HAEMORRHAGIC 3 0.0065
25 CYCLOTHYMIC DISORDER 1 0.0061
26 SMOKER 1 0.0053
27 HOSTILITY 13 0.0051
28 DELUSIONAL PERCEPTION 2 0.0048
29 PERICARDITIS CONSTRICTIVE 2 0.0047
30 REBOUND PSYCHOSIS 1 0.0047
31 AUTOMATISM 1 0.0046
32 WITHDRAWAL CATATONIA 1 0.0043
33 ILLNESS ANXIETY DISORDER 1 0.0041
34 DRUG INTERACTION POTENTIATION 1 0.0039
35 COAGULATION FACTOR DECREASED 1 0.0037
36 COLONIC PSEUDO-OBSTRUCTION 1 0.0036
37 PSYCHIATRIC DECOMPENSATION 7 0.0036
38 NEUROLEPTIC MALIGNANT SYNDROME 42 0.0035
39 AVERSION 1 0.0035
40 NEPHROGENIC DIABETES INSIPIDUS 4 0.0035
41 MYOPATHY TOXIC 2 0.0032
42 PARKINSONISM 31 0.0032
43 MUTISM 4 0.0028
44 PATIENT ELOPEMENT 1 0.0027
45 DIET REFUSAL 2 0.0027
46 RESPIRATORY GAS EXCHANGE DISORDER 1 0.0027
47 NEGATIVISM 2 0.0026
48 KETONURIA 2 0.0025
49 AKATHISIA 32 0.0023
50 HYPERAMMONAEMIC ENCEPHALOPATHY 4 0.0023
51 LENTICULAR OPACITIES 1 0.0023
52 SOCIAL AVOIDANT BEHAVIOUR 13 0.0022
53 ANAEMIA MEGALOBLASTIC 1 0.0022
54 DELUSION OF GRANDEUR 1 0.0022
55 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
56 HYPERCHOLESTEROLAEMIA 21 0.0022
57 DYSLIPIDAEMIA 11 0.0022
58 BLOOD PROLACTIN INCREASED 10 0.0021
59 THERAPY RESPONDER 1 0.0020
60 MARKEDLY REDUCED DIETARY INTAKE 1 0.0020
61 POOR PERSONAL HYGIENE 1 0.0019
62 VULVOVAGINAL INJURY 1 0.0018
63 GRANULOCYTOPENIA 10 0.0018
64 PANCREATITIS NECROTISING 4 0.0017
65 SLEEP WALKING 1 0.0017
66 FOLATE DEFICIENCY 2 0.0017
67 PROTRUSION TONGUE 1 0.0017
68 AGRAPHIA 1 0.0017
69 CONDUCTION DISORDER 3 0.0016
70 DELUSION 25 0.0016
71 PARKINSONIAN GAIT 1 0.0016
72 PRESSURE OF SPEECH 1 0.0015
73 CATATONIA 8 0.0015
74 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
75 SEDATION 38 0.0014
76 ANTICONVULSANT DRUG LEVEL DECREASED 2 0.0014
77 CARDIAC ENZYMES INCREASED 1 0.0014
78 APALLIC SYNDROME 1 0.0014
79 CORNEAL DEPOSITS 1 0.0013
80 DYSTONIA 26 0.0013
81 SCHIZOPHRENIA 16 0.0013
82 EMBOLIA CUTIS MEDICAMENTOSA 1 0.0013
83 DISINHIBITION 2 0.0012
84 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
85 PYLORIC STENOSIS 1 0.0012
86 SOLILOQUY 1 0.0012
87 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
88 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
89 STEREOTYPY 1 0.0011
90 PROSTATE INFECTION 1 0.0010
91 SEXUAL DYSFUNCTION 12 0.0010
92 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
93 ANTISOCIAL BEHAVIOUR 1 0.0010
94 SALIVARY HYPERSECRETION 10 0.0010
95 COGWHEEL RIGIDITY 1 0.0010
96 SOMATIC SYMPTOM DISORDER 1 0.0009
97 KETOSIS 1 0.0009
98 OLIGOMENORRHOEA 2 0.0009
99 BIPOLAR I DISORDER 2 0.0009
100 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
101 SICK SINUS SYNDROME 1 0.0009
102 METABOLIC DISORDER 5 0.0009
103 EXTRAPYRAMIDAL DISORDER 21 0.0008
104 PERSECUTORY DELUSION 2 0.0008
105 OBSTRUCTION GASTRIC 1 0.0008
106 BLOOD CHLORIDE DECREASED 2 0.0008
107 SINUS ARRHYTHMIA 1 0.0008
108 PERSONALITY DISORDER 2 0.0008
109 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
110 ACROCHORDON 1 0.0008
111 APATHY 11 0.0008
112 BRADYPNOEA 2 0.0007
113 BODY MASS INDEX INCREASED 1 0.0007
114 DIABETIC COMA 2 0.0007
115 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
116 JUDGEMENT IMPAIRED 1 0.0007
117 GENERALISED ANXIETY DISORDER 1 0.0007
118 BRADYKINESIA 4 0.0007
119 HEPATITIS FULMINANT 2 0.0007
120 MUSCLE RIGIDITY 8 0.0007
121 GINGIVAL HYPERTROPHY 1 0.0007
122 SUBSTANCE USE 1 0.0006
123 INAPPROPRIATE AFFECT 1 0.0006
124 GALACTORRHOEA 4 0.0006
125 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
126 RESPIRATORY ALKALOSIS 1 0.0006
127 PITUITARY TUMOUR BENIGN 1 0.0006
128 ABNORMAL BEHAVIOUR 24 0.0006
129 ILLUSION 1 0.0006
130 PRIAPISM 2 0.0006
131 PUPIL FIXED 1 0.0006
132 LOGORRHOEA 2 0.0006
133 DYSKINESIA 23 0.0006
134 WRONG DRUG ADMINISTERED 5 0.0006
135 PRODUCT TAMPERING 1 0.0006
136 DISORGANISED SPEECH 1 0.0005
137 ALCOHOL USE 2 0.0005
138 HYPOPROTEINAEMIA 1 0.0005
139 HYPERCOAGULATION 1 0.0005
140 MYOCARDITIS 6 0.0005
141 COMMUNICATION DISORDER 2 0.0005
142 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
143 HYPERTRIGLYCERIDAEMIA 3 0.0005
144 POLYDIPSIA 2 0.0005
145 AKINESIA 1 0.0005
146 SELF-INJURIOUS IDEATION 2 0.0005
147 DILATATION VENTRICULAR 1 0.0005
148 PSYCHOTIC DISORDER 14 0.0005
149 SUDDEN DEATH 5 0.0005
150 PHARYNGEAL ERYTHEMA 1 0.0005
151 DEREALISATION 1 0.0005
152 GYNAECOMASTIA 14 0.0005
153 CORNEAL OEDEMA 1 0.0004
154 HEPATOCELLULAR DAMAGE 1 0.0004
155 FLAT AFFECT 1 0.0004
156 PERSONALITY CHANGE 4 0.0004
157 PULMONARY INFARCTION 1 0.0004
158 AGGRESSION 21 0.0004
159 WEIGHT ABNORMAL 1 0.0004
160 DIABETES INSIPIDUS 1 0.0004
161 RHABDOMYOLYSIS 17 0.0004
162 FLUID INTAKE REDUCED 2 0.0004
163 DYSPHORIA 2 0.0004
164 HAEMODYNAMIC INSTABILITY 3 0.0004
165 PARKINSON'S DISEASE 1 0.0004
166 SEDATION COMPLICATION 1 0.0004
167 CACHEXIA 2 0.0004
168 COMPARTMENT SYNDROME 1 0.0004
169 TORSADE DE POINTES 3 0.0004
170 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
171 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
172 ALCOHOL POISONING 1 0.0004
173 SUBSTANCE ABUSE 3 0.0004
174 TIC 2 0.0004
175 COGNITIVE DISORDER 17 0.0004
176 HYPERTONIA 2 0.0003
177 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
178 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
179 NEGATIVE THOUGHTS 1 0.0003
180 ANAL INCONTINENCE 3 0.0003
181 BONE MARROW DISORDER 1 0.0003
182 SUICIDE ATTEMPT 20 0.0003
183 TENSION 2 0.0003
184 RESPIRATORY DEPRESSION 4 0.0003
185 FIBROSIS 1 0.0003
186 ARTERIOSCLEROSIS 3 0.0003
187 SCREAMING 2 0.0003
188 STUPOR 1 0.0003
189 INCOHERENT 2 0.0003
190 HYPERPROLACTINAEMIA 2 0.0003
191 HYPOVENTILATION 1 0.0003
192 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
193 THERAPEUTIC AGENT TOXICITY 1 0.0003
194 URINARY RETENTION 10 0.0003
195 TACHYPNOEA 4 0.0003
196 TREATMENT NONCOMPLIANCE 16 0.0003
197 DROOLING 2 0.0003
198 TACHYPHRENIA 1 0.0003
199 MICTURITION DISORDER 1 0.0003
200 TARDIVE DYSKINESIA 8 0.0003
201 MACULOPATHY 1 0.0003
202 FRUSTRATION 1 0.0003
203 SEBORRHOEA 1 0.0003
204 HYPOMANIA 1 0.0003
205 WOUND HAEMORRHAGE 1 0.0003
206 TROPONIN INCREASED 2 0.0003
207 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
208 ACIDOSIS 2 0.0003
209 FAECES HARD 1 0.0003
210 AFFECTIVE DISORDER 2 0.0003
211 HALLUCINATION, AUDITORY 4 0.0003
212 AZOTAEMIA 1 0.0003
213 POLYURIA 2 0.0002
214 SMALL INTESTINAL OBSTRUCTION 3 0.0002
215 SELF-MEDICATION 1 0.0002
216 ANAPHYLACTOID REACTION 1 0.0002
217 ILEUS 3 0.0002
218 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
219 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 1 0.0002
220 SUICIDAL BEHAVIOUR 1 0.0002
221 MONOPLEGIA 1 0.0002
222 PAPILLOEDEMA 1 0.0002
223 DRUG INTERACTION 35 0.0002
224 VASCULAR DEVICE INFECTION 1 0.0002
225 MUSCLE TWITCHING 5 0.0002
226 SINUS TACHYCARDIA 3 0.0002
227 DIABETES MELLITUS 16 0.0002
228 NON-SMALL CELL LUNG CANCER 1 0.0002
229 FAECAL INCONTINENCE 1 0.0002
230 DIABETIC NEUROPATHY 1 0.0002
231 MULTIPLE DRUG OVERDOSE 1 0.0002
232 HYPERAMMONAEMIA 1 0.0002
233 DRUG TOLERANCE 1 0.0002
234 DRUG LEVEL DECREASED 2 0.0002
235 MOTOR DYSFUNCTION 2 0.0002
236 PETIT MAL EPILEPSY 1 0.0002
237 FEMORAL NECK FRACTURE 1 0.0002
238 DRUG EFFECT INCOMPLETE 7 0.0002
239 THERAPY PARTIAL RESPONDER 3 0.0002
240 PHARYNGOLARYNGEAL PAIN 1 0.0002
241 DYSARTHRIA 7 0.0002
242 DECREASED ACTIVITY 2 0.0002
243 BEHAVIOUR DISORDER 1 0.0002
244 BIPOLAR DISORDER 2 0.0002
245 FAECALOMA 1 0.0002
246 LEUKOPENIA 9 0.0002
247 CIRCULATORY COLLAPSE 3 0.0002
248 VISUAL DISTURBANCE 1 0.0002
249 PARANOIA 3 0.0002
250 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
251 MOUTH SWELLING 1 0.0002
252 PRODUCT LABEL CONFUSION 1 0.0002
253 HYPOVOLAEMIA 1 0.0002
254 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
255 PROTHROMBIN TIME PROLONGED 1 0.0002
256 SYMPTOM RECURRENCE 1 0.0002
257 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
258 NO THERAPEUTIC RESPONSE 2 0.0002
259 AGRANULOCYTOSIS 3 0.0002
260 THINKING ABNORMAL 3 0.0002
261 SWELLING OF EYELID 1 0.0002
262 BLEPHAROSPASM 1 0.0002
263 BRAIN OEDEMA 2 0.0002
264 LETHARGY 9 0.0002
265 DRUG RESISTANCE 4 0.0002
266 BRADYPHRENIA 1 0.0002
267 SOMNAMBULISM 1 0.0002
268 DYSGRAPHIA 1 0.0002
269 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
270 AGITATION 11 0.0001
271 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
272 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
273 INTENTIONAL SELF-INJURY 3 0.0001
274 TYPE 2 DIABETES MELLITUS 5 0.0001
275 PRODUCT ADMINISTRATION ERROR 3 0.0001
276 WRONG PRODUCT ADMINISTERED 1 0.0001
277 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
278 EYE MOVEMENT DISORDER 1 0.0001
279 ONYCHOCLASIS 1 0.0001
280 HYPERTRANSAMINASAEMIA 1 0.0001
281 COORDINATION ABNORMAL 2 0.0001
282 WITHDRAWAL SYNDROME 6 0.0001
283 RIGHT VENTRICULAR FAILURE 1 0.0001
284 HYPONATRAEMIA 8 0.0001
285 SUICIDAL IDEATION 13 0.0001
286 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
287 WEIGHT INCREASED 31 0.0001
288 HYPERGLYCAEMIA 5 0.0001
289 MUSCULOSKELETAL STIFFNESS 12 0.0001
290 RESTLESSNESS 5 0.0001
291 PSYCHIATRIC SYMPTOM 1 0.0001
292 PAROSMIA 1 0.0001
293 DISSOCIATION 1 0.0001
294 CONGENITAL ANOMALY 1 0.0001
295 NICOTINE DEPENDENCE 1 0.0001
296 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
297 MUSCLE DISORDER 1 0.0001
298 FLATULENCE 7 0.0001
299 ASPHYXIA 1 0.0001
300 MANIA 2 0.0001
301 DRUG LEVEL INCREASED 2 0.0001
302 MENSTRUAL DISORDER 1 0.0001
303 TREMOR 20 0.0001
304 HEMIPLEGIA 1 0.0001
305 PNEUMONIA ASPIRATION 3 0.0001
306 HALLUCINATION 9 0.0001
307 PRODUCT CONTAINER ISSUE 1 0.0001
308 ORTHOSTATIC HYPOTENSION 2 0.0001
309 CONSTIPATION 25 0.0001
310 LUNG INFILTRATION 1 0.0001
311 CARDIOTOXICITY 1 0.0001
312 ADVERSE DRUG REACTION 10 0.0001
313 RASH PRURITIC 6 0.0001
314 LEUKOCYTOSIS 2 0.0001
315 ACCIDENTAL OVERDOSE 4 0.0001
316 CARDIAC ARREST 9 0.0001
317 GRAND MAL CONVULSION 1 0.0001
318 MENTAL STATUS CHANGES 3 0.0001
319 CONJUNCTIVITIS 2 0.0001
320 LACERATION 1 0.0001
321 INCREASED APPETITE 2 0.0001
322 URINARY INCONTINENCE 3 0.0001
323 HAEMATOCRIT DECREASED 2 0.0001
324 INABILITY TO AFFORD MEDICATION 1 0.0001
325 APHASIA 3 0.0001
326 FEEDING DISORDER 2 0.0001
327 SUBARACHNOID HAEMORRHAGE 1 0.0001
328 EPILEPSY 3 0.0001
329 INITIAL INSOMNIA 1 0.0001
330 TREATMENT FAILURE 8 0.0001
331 RESPIRATORY FAILURE 7 0.0001
332 TENDERNESS 1 0.0001
333 UNDERDOSE 7 0.0001
334 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
335 CARDIO-RESPIRATORY ARREST 4 0.0001
336 VISION BLURRED 13 0.0001
337 INCONTINENCE 1 0.0001
338 EATING DISORDER 2 0.0001
339 MOVEMENT DISORDER 3 0.0001
340 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
341 OEDEMA 5 0.0001
342 ASPIRATION 1 0.0001
343 VISUAL ACUITY REDUCED 3 0.0001
344 NERVE INJURY 1 0.0001
345 MALNUTRITION 1 0.0001
346 PULMONARY OEDEMA 4 0.0001
347 CHROMATURIA 2 0.0001
348 MYOCARDIAL ISCHAEMIA 1 0.0001
349 DERMATITIS CONTACT 1 0.0001
350 CONVULSION 5 0.0001
351 DELIRIUM 3 0.0001
352 ELECTROLYTE IMBALANCE 1 0.0001
353 EYELID OEDEMA 1 0.0001
354 SPINAL PAIN 1 0.0001
355 DYSPHAGIA 8 0.0001
356 DRUG ABUSE 7 0.0001
357 COMA 4 0.0001
358 MACULAR DEGENERATION 1 0.0001
359 DIABETIC KETOACIDOSIS 2 0.0001
360 TOXICITY TO VARIOUS AGENTS 14 0.0001
361 MENTAL IMPAIRMENT 2 0.0001
362 THERAPEUTIC RESPONSE DECREASED 5 0.0001
363 LUNG DISORDER 4 0.0001
364 DYSURIA 3 0.0001
365 ENCEPHALOPATHY 2 0.0001
366 ABASIA 2 0.0001
367 GENERALISED OEDEMA 1 0.0001
368 POISONING 1 0.0001
369 HAEMATEMESIS 2 0.0001
370 TACHYCARDIA 7 0.0001
371 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
372 ANOREXIA 1 0.0001
373 UNRESPONSIVE TO STIMULI 2 0.0001
374 PLATELET COUNT INCREASED 1 0.0001
375 APPLICATION SITE ERYTHEMA 2 0.0001
376 FEAR 2 0.0001
377 PNEUMONITIS 2 0.0001
378 DRUG TOXICITY 1 0.0001
379 GINGIVAL BLEEDING 1 0.0001
380 MEDICATION ERROR 4 0.0001
381 BLINDNESS UNILATERAL 1 0.0001
382 RED BLOOD CELL COUNT DECREASED 2 0.0001
383 PARALYSIS 1 0.0001
384 CARDIOGENIC SHOCK 1 0.0001
385 MENTAL DISORDER 3 0.0001
386 HYPOKINESIA 1 0.0001
387 THERAPY NON-RESPONDER 3 0.0001
388 DRUG DISPENSING ERROR 1 0.0001
389 RENAL DISORDER 3 0.0001
390 EJECTION FRACTION DECREASED 1 0.0001
391 CYANOSIS 1 0.0001
392 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
393 OBESITY 1 0.0001
394 MOOD SWINGS 2 0.0001
395 HYPOTHYROIDISM 2 0.0001
396 METABOLIC ACIDOSIS 2 0.0001
397 MUSCLE TIGHTNESS 1 0.0001
398 BLOOD POTASSIUM INCREASED 1 0.0001
399 SEIZURE 7 0.0001
400 VENTRICULAR TACHYCARDIA 1 0.0001
401 EXPIRED PRODUCT ADMINISTERED 2 0.0001
402 BLOOD UREA INCREASED 1 0.0001
403 PERICARDITIS 1 0.0001
404 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
405 CHEST PAIN 11 0.0001
406 ANGER 2 0.0001
407 SCAR 1 0.0001
408 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
409 NEUROTOXICITY 1 0.0001
410 EOSINOPHILIA 1 0.0001
411 HYPERKALAEMIA 2 0.0001
412 HYPOXIA 2 0.0001
413 LYMPHOCYTE COUNT DECREASED 1 0.0001
414 BRADYCARDIA 3 0.0001
415 HEAD DISCOMFORT 1 0.0001
416 GALLBLADDER DISORDER 1 0.0001
417 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
418 DISTURBANCE IN ATTENTION 3 0.0001
419 OVERDOSE 12 0.0001
420 RESTLESS LEGS SYNDROME 1 0.0001
421 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
422 BACTERIAL INFECTION 1 0.0001
423 PHOTOPHOBIA 1 0.0001
424 BLOOD SODIUM DECREASED 1 0.0001
425 HYPOCALCAEMIA 1 0.0001
426 SLEEP APNOEA SYNDROME 1 0.0001
427 PULMONARY FIBROSIS 1 0.0001
428 ACUTE RESPIRATORY FAILURE 1 0.0001
429 PRESCRIBED OVERDOSE 1 0.0001
430 NEUTROPENIA 7 0.0001
431 ATRIAL FIBRILLATION 5 0.0001
432 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
433 DISORIENTATION 2 0.0001
434 PRESCRIBED UNDERDOSE 1 0.0001
435 IRRITABILITY 3 0.0000
436 DRY MOUTH 4 0.0000
437 BONE MARROW FAILURE 1 0.0000
438 NEUTROPHIL COUNT DECREASED 2 0.0000
439 INTENTIONAL DRUG MISUSE 1 0.0000
440 RENAL IMPAIRMENT 4 0.0000
441 HALLUCINATION, VISUAL 1 0.0000
442 RETCHING 1 0.0000
443 LOSS OF CONSCIOUSNESS 6 0.0000
444 HYPERHIDROSIS 6 0.0000
445 POOR QUALITY SLEEP 1 0.0000
446 AMNESIA 3 0.0000
447 PRODUCT PRESCRIBING ISSUE 1 0.0000
448 SEPSIS 5 0.0000
449 SNEEZING 1 0.0000
450 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
451 PANCREATITIS ACUTE 1 0.0000
452 APPLICATION SITE PRURITUS 1 0.0000
453 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
454 PRODUCT AVAILABILITY ISSUE 1 0.0000
455 HYPOKALAEMIA 2 0.0000
456 ARRHYTHMIA 2 0.0000
457 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
458 ANXIETY 12 0.0000
459 PULMONARY EMBOLISM 4 0.0000
460 PRODUCT PRESCRIBING ERROR 1 0.0000
461 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
462 DRUG INTOLERANCE 4 0.0000
463 LOCALISED INFECTION 1 0.0000
464 PRESYNCOPE 1 0.0000
465 LIVER INJURY 1 0.0000
466 PYREXIA 14 0.0000
467 DRUG INEFFECTIVE 53 0.0000
468 SYNCOPE 4 0.0000
469 HYPOPHAGIA 1 0.0000
470 HEPATITIS 1 0.0000
471 ERECTILE DYSFUNCTION 1 0.0000
472 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
473 DIPLOPIA 1 0.0000
474 RESPIRATORY TRACT INFECTION 1 0.0000
475 NERVOUSNESS 2 0.0000
476 MUCOSAL INFLAMMATION 1 0.0000
477 SPEECH DISORDER 2 0.0000
478 PANCREATITIS 2 0.0000
479 DEPRESSED MOOD 2 0.0000
480 DEHYDRATION 5 0.0000
481 CARDIAC FAILURE 3 0.0000
482 DRUG EFFECT DECREASED 2 0.0000
483 LIMB INJURY 1 0.0000
484 MOOD ALTERED 1 0.0000
485 ABNORMAL DREAMS 1 0.0000
486 COMPLETED SUICIDE 3 0.0000
487 WOUND 1 0.0000
488 OXYGEN SATURATION DECREASED 2 0.0000
489 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
490 DYSSTASIA 1 0.0000
491 CATARACT 2 0.0000
492 HYPERTENSION 7 0.0000
493 CORONARY ARTERY DISEASE 1 0.0000
494 VERTIGO 2 0.0000
495 DRUG ADMINISTRATION ERROR 1 0.0000
496 OROPHARYNGEAL PAIN 3 0.0000
497 NERVOUS SYSTEM DISORDER 1 0.0000
498 HEAD INJURY 1 0.0000
499 GAIT DISTURBANCE 6 0.0000
500 DRUG DEPENDENCE 5 0.0000
501 BLOOD PRESSURE DECREASED 2 0.0000
502 VIRAL INFECTION 1 0.0000
503 HYPOTENSION 6 0.0000
504 SOMNOLENCE 6 0.0000
505 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
506 CONDITION AGGRAVATED 9 0.0000
507 NEOPLASM PROGRESSION 1 0.0000
508 RASH MACULAR 1 0.0000
509 LYMPHADENOPATHY 1 0.0000
510 C-REACTIVE PROTEIN INCREASED 1 0.0000
511 PANIC ATTACK 1 0.0000
512 INJECTION SITE MASS 1 0.0000
513 DYSPNOEA EXERTIONAL 1 0.0000
514 UNEVALUABLE EVENT 2 0.0000
515 INSOMNIA 7 0.0000
516 WEIGHT DECREASED 7 0.0000
517 CARDIAC FAILURE CONGESTIVE 2 0.0000
518 ABDOMINAL PAIN UPPER 5 0.0000
519 VISUAL IMPAIRMENT 3 0.0000
520 POLLAKIURIA 1 0.0000
521 MYOCARDIAL INFARCTION 4 0.0000
522 LIVER DISORDER 1 0.0000
523 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
524 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
525 PRODUCT QUALITY ISSUE 3 0.0000
526 SKIN DISCOLOURATION 1 0.0000
527 ADVERSE EVENT 2 0.0000
528 BLOOD CHOLESTEROL INCREASED 1 0.0000
529 FALL 7 0.0000
530 HYPOGLYCAEMIA 1 0.0000
531 DYSPEPSIA 2 0.0000
532 HAEMOGLOBIN DECREASED 2 0.0000
533 ECZEMA 1 0.0000
534 MUSCULOSKELETAL PAIN 1 0.0000
535 CONFUSIONAL STATE 3 0.0000
536 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
537 DEPENDENCE 1 0.0000
538 ARTHROPATHY 1 0.0000
539 NECK PAIN 1 0.0000
540 MUSCULAR WEAKNESS 2 0.0000
541 DEPRESSION 4 0.0000
542 PALPITATIONS 2 0.0000
543 BONE PAIN 1 0.0000
544 PAIN IN EXTREMITY 5 0.0000
545 DISEASE PROGRESSION 2 0.0000
546 WHEEZING 1 0.0000
547 JOINT SWELLING 2 0.0000
548 ILL-DEFINED DISORDER 1 0.0000
549 PLEURAL EFFUSION 1 0.0000
550 DISCOMFORT 1 0.0000
551 FEELING HOT 1 0.0000
552 INJECTION SITE ERYTHEMA 2 0.0000
553 DIZZINESS 8 0.0000
554 DYSPNOEA 9 0.0000
555 ANAEMIA 3 0.0000
556 INTENTIONAL OVERDOSE 1 0.0000
557 PNEUMONIA 5 0.0000
558 BLOOD CREATININE INCREASED 1 0.0000
559 FEBRILE NEUTROPENIA 1 0.0000
560 COUGH 4 0.0000
561 SLEEP DISORDER 1 0.0000
562 THERAPY INTERRUPTED 1 0.0000
563 MOBILITY DECREASED 1 0.0000
564 PRODUCT DOSE OMISSION ISSUE 4 0.0000
565 HYPOAESTHESIA 2 0.0000
566 ACUTE KIDNEY INJURY 2 0.0000
567 INJECTION SITE PAIN 4 0.0000
568 DECREASED APPETITE 3 0.0000
569 ABDOMINAL PAIN 3 0.0000
570 VOMITING 6 0.0000
571 OFF LABEL USE 11 0.0000
572 FEELING ABNORMAL 3 0.0000
573 INFLUENZA LIKE ILLNESS 1 0.0000
574 DRUG DOSE OMISSION 2 0.0000
575 ABDOMINAL DISCOMFORT 2 0.0000
576 SKIN EXFOLIATION 1 0.0000
577 MYALGIA 2 0.0000
578 COVID-19 2 0.0000
579 BREAST CANCER 1 0.0000
580 ASTHENIA 4 0.0000
581 BLOOD GLUCOSE INCREASED 2 0.0000
582 NEUROPATHY PERIPHERAL 1 0.0000
583 PRURITUS 4 0.0000
584 CONTUSION 1 0.0000
585 FATIGUE 8 0.0000
586 ALOPECIA 2 0.0000
587 HEART RATE INCREASED 1 0.0000
588 FLUSHING 1 0.0000
589 SINUSITIS 1 0.0000
590 ARTHRALGIA 4 0.0000
591 ABDOMINAL DISTENSION 1 0.0000
592 PLATELET COUNT DECREASED 1 0.0000
593 DIARRHOEA 6 0.0000
594 THROMBOCYTOPENIA 1 0.0000
595 INCORRECT DOSE ADMINISTERED 2 0.0000
596 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
597 BACK PAIN 2 0.0000
598 CHILLS 1 0.0000
599 EMOTIONAL DISTRESS 1 0.0000
600 OEDEMA PERIPHERAL 1 0.0000
601 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
602 RENAL FAILURE 1 0.0000
603 DRY SKIN 1 0.0000
604 MEMORY IMPAIRMENT 1 0.0000
605 INFECTION 1 0.0000
606 RASH 3 0.0000
607 HOSPITALISATION 1 0.0000
608 NAUSEA 5 0.0000
609 URTICARIA 1 0.0000
610 CEREBROVASCULAR ACCIDENT 1 0.0000
611 URINARY TRACT INFECTION 1 0.0000
612 NO ADVERSE EVENT 1 0.0000
613 MUSCLE SPASMS 1 0.0000
614 NASOPHARYNGITIS 1 0.0000
615 HYPERSENSITIVITY 1 0.0000
616 PRODUCT USE ISSUE 1 0.0000
617 DEATH 3 0.0000
618 PAIN 2 0.0000
619 HEADACHE 2 0.0000
620 MALAISE 1 0.0000